News
Texas Attorney General Ken Paxton is accusing Eli Lilly and Co. of a kickback scheme to induce medical providers to prescribe ...
The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...
A UK government and Eli Lilly £85 million program will expand obesity care nationwide, offering digital, community, and ...
Counterfeit drugs infiltrating the US pharma supply chain through gray market channels underscore the urgent need for ...
Novo Nordisk A/S (NYSE:NVO) is among the. Novo Nordisk A/S (NYSE:NVO) lowered its operating profit growth projections to ...
If you’re pregnant or hoping to become pregnant, it’s natural to have questions about your medications. And if you’re taking ...
Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...
Corporate lobbying shop Ballard Partners previously employed Donald Trump’s chief of staff as well as his attorney general.
Doctors suggest that anybody with a Body mass index of over 30 or greater than 27 is advised to try weight loss drugs.
Novo Nordisk's steep stock decline has pushed it into deep undervaluation, now trading at attractive multiples below ...
For dividend-seeking investors, a buoyant stock market can be a little annoying. Stock prices rising faster than profits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results